On Friday afternoon, 15 December 2017, the 27th session of the WIPO Standing Committee on the Law of Patents (SCP) agreed to a future program of work that included the following topics: 1) Exceptions and Limitations to Patent Rights, 2)… Continue Reading
On December 13, 2017, a joint statement on e-commerce was endorsed by Ministers representing 70 WTO members at the 11th WTO Ministerial Conference in Buenos Aires, Argentina (see below). KEI’s statement on the WTO e-commerce agenda is as follows: “There… Continue Reading
On Tuesday, 12 December 2017, the South African delegation to the WIPO Standing Committee on the Law of Patents (SCP) delivered the following statement on patents and health. South Africa reiterated its strong support for the Report of the UN… Continue Reading
On 12 December 2017, KEI delivered the following intervention to WIPO on pressures faced by Brazil and Colombia in using TRIPS flexibilities. 12 December 2017 SCP 27 Thank you Chair. We welcome the opportunity to provide inputs on the constraints… Continue Reading
On Tuesday, 12 December 2017, Knowledge Ecology International delivered the following intervention at the 27th session of the WIPO Standing Committee of the Law of Patents during discussions of a work program on patents and health. Knowledge Ecology International reiterates… Continue Reading
On Monday, 11 December 2017, KEI delivered the following statement in response to WIPO’s publication of a Draft Reference Document on Exception Regarding Acts for Obtaining Regulatory Approval from Authorities. KEI commends the work of the WIPO secretariat in preparing… Continue Reading
On Monday, 11 December 2017, Indonesia, on behalf of the Asia Pacific Group, delivered the following opening statement at the 27th session of the WIPO Standing Committee on the Law of Patents (SCP). The Asia Pacific Group issued a clarion… Continue Reading
On 8 December 2017, Knowledge Ecology International (KEI) submitted the following paper on “constraints faced by developing countries and least developed countries (LDCs) in making full use of patent flexibilities and their impacts” on access to medicines pursuant to the decision… Continue Reading
For more information, contact: (U.S.) James Love, KEI: james.love@keionline.org or +1 (202) 332-2670 (Chile) Luis Villaroel, Innovarte: info@innovarte.cl or +56 9 9827 9673 Chile FAQ What is happening in Chile with regard to HCV medicines and Xtandi, for prostate cancer?… Continue Reading
FOR IMMEDIATE RELEASE Contact: Kim Treanor kim.treanor@keionline.org; 202-332-2670 Patient groups, civil society and concerned individuals from Chile and around the world call upon President Michelle Bachelet Jeria and Dr. Carmen Castillo Taucher, Minister of Health, to issue a compulsory license… Continue Reading